Copy link
Export CSV
Cite this view
HANK Price Transparency. (n.d.).
GEMCITABINE 225MG INTRAVESICAL (OTHER 63638670) by State .
PPMan price-transparency data, derived from CMS-required hospital MRFs.
Retrieved July 2, 2026 , from http://ppman.hank.ai/transparency/procedure/63638670/by-state?code_type=OTHER
“GEMCITABINE 225MG INTRAVESICAL (OTHER 63638670) by State.” HANK Price Transparency ,
http://ppman.hank.ai/transparency/procedure/63638670/by-state?code_type=OTHER. Accessed
July 2, 2026 .
“GEMCITABINE 225MG INTRAVESICAL (OTHER 63638670) by State,” HANK Price Transparency ,
accessed July 2, 2026 ,
http://ppman.hank.ai/transparency/procedure/63638670/by-state?code_type=OTHER.
Source: PPMan price-transparency data, derived from CMS-required hospital
machine-readable files (45 CFR 180). See
methodology .
Print / Save PDF
OTHER · across United States
63638670 — Gemcitabine 225mg Intravesical
State-by-state median negotiated rates. Lower bars are cheaper states; the
range bar shows the IQR (25th to 75th percentile within each state).
$96,419
National median
$88,595 – $117,248
IQR (p25 – p75)
10
hospitals filing
2
states
Median negotiated rate, by state
Ranked by typical (median) negotiated price. Hover for state-level IQR.
Median negotiated rate by state for 63638670 (OTHER), with interquartile range
State Median p25 p75
DC $100,912 $82,110 $114,928
MD $96,419 $88,595 $117,248